Send to

Choose Destination
J Hypertens. 2014 Jul;32(7):1367-78. doi: 10.1097/HJH.0000000000000213.

European consensus on the diagnosis and management of fibromuscular dysplasia.

Author information

aPole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain bDivision of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium cAssistance Publique - Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Hypertension Unit, Paris, France dDepartment of Internal Medicine and Hypertension Center, San Giuseppe Hospital, University of Milan, Milan, Italy eUniversité Caen Basse Normandie, Inserm U919, CHU Côte de Nacre, Caen, France fDepartment of Hypertension, Institute of Cardiology, Warsaw, Poland gAssistance Publique - Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Interventional Radiology Unit, Paris hUniversité Paris-Descartes, Paris Sorbonne Cité, Paris iDepartment of Vascular Surgery, CHU Hôpital Nord, Saint-Etienne jINSERM, U970, PARCC, Paris, France kDepartment of Medicine, University Hospital Maastricht, Maastricht, The Netherlands.


The main objectives of this expert consensus are to raise awareness about fibromuscular dysplasia, which is more frequent and more often systemic than previously thought and can sometimes have devastating consequences; to provide up-to-date recommendations for the diagnosis, evaluation, and management of the disease; and to identify research priorities. The emphasis has been put on recommendations for daily practice. The main topics covered include definition, classification, diagnosis, and management of fibromuscular dysplasia in adult patients with symptomatic involvement of the renal arteries, supra-aortic trunks, and digestive and peripheral arteries.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center